Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer

The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as ...

Is Eli Lilly a Millionaire Maker?

Weight loss drugs are set to become a disproportionate share of Lilly's business.

Hims shares rise on talks to offer Novo’s new obesity pill

Hims and Hers Health Inc. rose after the telehealth company said it was in talks with Novo Nordisk A/S to sell its ...
Healio

Shifting PCSK9 inhibition ‘upstream’ for high-risk primary prevention

PCSK9 inhibition may be a suitable alternative for statin-intolerant patients, and recent data demonstrated its efficacy as ...
Iowa Public Radio

Searching 'weight' can bring up Ozempic in results. It's a drug advertising loophole

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle room when companies pay to sponsor online search results.

Pfizer, Novo Boost Bids for Obesity Drugmaker Metsera in Takeover Saga

Pfizer Inc. and Novo Nordisk A/S boosted their bids for Metsera Inc. as the ongoing battle for the obesity startup intensified ahead of a court battle slated for Tuesday, underscoring the surging ...